Aprepitant and Heparin sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aprepitant (aprepitant) and Heparin sodium (heparin sodium). Common drug interactions include slow response to stimuli among females and platelet count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Aprepitant and Heparin sodium. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Aprepitant?

Aprepitant has active ingredients of aprepitant. eHealthMe is studying from 6,992 Aprepitant users. Check the latest studies of Aprepitant.

What is Heparin sodium?

Heparin sodium has active ingredients of heparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 21,065 Heparin sodium users. Check the latest studies of Heparin sodium.

On Jul, 17, 2026

47 people who take Aprepitant and Heparin sodium together, and have interactions are studied.

Aprepitant and Heparin sodium drug interactions.

What are the common drug interactions of Aprepitant and Heparin Sodium, by gender? *:

female:

Slow response to stimuli (slow response by nerves)
Staphylococcus test positive
Stomatitis (inflammation of mucous membrane of mouth)
Therapeutic response decreased (less preventive response)
Tremor (trembling or shaking movements in one or more parts of your body)
Bone marrow failure
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Febrile neutropenia (fever with reduced white blood cells)
Hyperkalaemia (damage to or disease of the kidney)
Oxygen saturation decreased

male:

Platelet count decreased
Decreased appetite
Asthenia (weakness)
Back pain
Cardiac failure
Chest discomfort
Chest pain
Colitis (inflammation of colon)
Dermatitis allergic (inflammation of the skin due allergic reaction)
Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Aprepitant and Heparin Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Febrile neutropenia (fever with reduced white blood cells)
Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Hypokalaemia (low potassium)
Neutropenia (an abnormally low number of neutrophils)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

10-19:

Fatigue (feeling of tiredness)
Haemorrhage (bleeding)
Headache (pain in head)
Hepatotoxicity (chemical-driven liver damage)
Hypotension (abnormally low blood pressure)
Malignant neoplasm progression (cancer tumour came back)
Memory impairment
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Mouth haemorrhage (bleeding from mouth)
Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)

20-29:

n/a

30-39:

n/a

40-49:

Anaemia (lack of blood)
Coagulopathy (blood's ability to clot is impaired)
Haemoperitoneum (presence of blood in the peritoneal cavity)
Post procedural haemorrhage (post procedural bleeding)

50-59:

Gastritis (inflammation of stomach)
Abdominal distension
Back pain
Cardiac failure
Chest discomfort
Chest pain
Colitis (inflammation of colon)
Constipation
Dermatitis allergic (inflammation of the skin due allergic reaction)
Dyspnoea (difficult or laboured respiration)

60+:

Platelet count decreased
Anaemia (lack of blood)
Dyspnoea exertional (breathlessness or shortness of breath)
Hyperkalaemia (damage to or disease of the kidney)
Obstruction gastric (obstruction in stomach)
Pneumonia
Urinary tract infection
Atrial thrombosis (blood clot that develops in an artery)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Confusional state

What are the existing conditions these people have? *

Constipation: 10 people, 21.28%
Stress And Anxiety: 9 people, 19.15%
Bone Marrow Conditioning Regimen: 9 people, 19.15%
Nausea (feeling of having an urge to vomit): 7 people, 14.89%
Hypersensitivity: 7 people, 14.89%
Nausea And Vomiting: 6 people, 12.77%
Rashes (redness): 5 people, 10.64%
Ovarian Cancer (cancer of ovary): 5 people, 10.64%
Insomnia (sleeplessness): 5 people, 10.64%
Upper Gastrointestinal Haemorrhage (upper gastrointestinal bleeding): 4 people, 8.51%

* Approximation only. Some reports may have incomplete information.

Do you take Aprepitant and Heparin sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously